期刊文献+

壳聚糖GFP质粒纳米粒对肿瘤细胞的转染效率研究 被引量:1

STUDY ON THE TRANSFECTION EFFICIENCY OF CHITOSAN-DNA NANOPARTICLES
下载PDF
导出
摘要 用绿色荧光蛋白(GFP)基因做报告基因,制备壳聚糖GFP质粒纳米粒,体外转染人肝癌细胞HepG2和肺癌细胞A549,定性评价纳米粒的转染效率和细胞毒性。结果表明壳聚糖GFP质粒纳米粒能转染两种细胞并在表达GFP,但两种细胞的转染效率不同,且该纳米粒能抑制两种细胞生长。 Chitosan-plasmid nanoparticles are prepared with GFP gene as reporter gene. and toxicity of the nanoparticles are investigated by transfecting HepG2 and A549 . The plasmid can be ferried into HepG2 and A549 and be translated into protein successfully. differently between HepG2 and A549. And the nanoparticles inhibit the proliferation of The transfection efficiency results show that the GFP But the cell uptake ratio is the two kinds cell lines.
出处 《武汉工业学院学报》 CAS 2005年第3期15-17,共3页 Journal of Wuhan Polytechnic University
基金 国家自然科学基金资助(30170051)
关键词 壳聚糖 质粒 纳米粒 转染 细胞活力 chitosan plasmid nanoparticle transfection cell viablity
  • 相关文献

参考文献11

  • 1Verma I m, Somia N. Gene therapy-promises,Problems and Prospects[ J]. Nature, 1997,289 :239 -242.
  • 2Arhsall E. Gene Therapy Death Prompts Review of Adenovirus Vector [ J ]. Science, 2000,286 :2244 -2245.
  • 3Roy K, Mao HQ, Huang SK, et al. Oral Gene Delivery with Chitosan-DNA Nanoparticles Generates Immunologic Protection in A MurineModel of Peanut Allergy[J]. Nat Med, 1999,5(4) :387-391.
  • 4MacLaughlin FC, Mumper ILl, Wang JJ,et al. ,Chitosan and Depolymerized Chitosan Oligomers as Condensing Carriers for in Vivo Plasmid Delivery [ J ]. J Controlled Release, 1998,56( 1-3 ) :259-272.
  • 5Richardson SCW, Kolbe HJV, Duncan R.Potential of Low Molecular Mass Chitosan as A DNA Delivery System: Biocompatibility, Body Distribution and Ability to Complex and Protect DNA[J]. Int J Pharm. 1999,178 (2) :231-243.
  • 6Chew JL, Wolfowicz CB, Mao HQ, et al.Chitosan Nanoparticles Containing Plasmid DNA Encoding House Dust Mite Allergen, Der p 1 for Oral Vaccination in Mice [ J ]. Vaccine, 2003,21 (21-22) :2720-2729.
  • 7Richardson SCW, Kolbe HJV, Duncan R.Potential of Low Molecular Mass Chitosan as A DNA Delivery System: Biocompatibility, Body Distribution and Ability to Complex and Protect DNA[J]. Int J Pharm,1999,178 (2) :231-243.
  • 8MacLaughlin FC, Mumper ILl, Wang JJ,et al.Chitosan and Depolymerized Chitosan Oligomers as Condensing Carriers for in Vivo Plasmid Delivery I J ]. J Controlled Release, 1998,56( 1-3 ) : 259-272.
  • 9Mao HQ, Roy K, Troung-Le VL, et al.Chitosan-DNA Nanoparticles as Gene Carriers:Synthesis, Characterization and Transfection Efficiency [ J]. J Control Release, 2001,70(3) :399-421.
  • 10Tugce D, Kadir T. In Vitro Characterization and Delivery of Chitosan-DNA Microparticlesin to Mammalian Cells [ J ]. J Pharm Pharmaceut Sci,2004, 7(2) :205-214.

同被引文献13

  • 1宗莉,陈伶俐,张淑芸,杨晓容,朱家壁.壳聚糖纳米粒作为基因载体的研究:制备,特征和对DNA的保护[J].中国药科大学学报,2005,36(6):526-530. 被引量:16
  • 2程东,韩晓英,冯宁,张天亮,李慧.壳聚糖的毒性研究[J].现代预防医学,2006,33(2):162-164. 被引量:18
  • 3Garnett M C. Gene-delivery systems using cationic polymers(J). Critical Reviews in Therapeutic Drug Carrier Systems, 1999, 16(2): 147-207.
  • 4Lotze M T, Frana L W, Sharrow S O, Robb R J and Rosenberg S A. In vivo administration of purified human intefleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2 (J). The Journal of Immunology, 1985, 134:157-166.
  • 5Mao H Q, Roy K, Troung-Le V L, Janes K A, Lina K Y, Wang Y, Augustb J T and Leong K W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency (J). Journal of Controlled Release, 2001, 70: 399-421.
  • 6Onishi H and Machida Y. Biodegradation and distribution of water-soluble chitosan in mice(J). Biomaterials, 1999, 20(2): 175-182.
  • 7Pang S W, Park H Y, Jang Y S, Kim W S and Kim J H. Effects of charge density and particle size of poly (styrene/(dimethylamino)ethyl methacrylate) nanoparticle for gene delivery in 293 cells (J). Colloids and Surfaces. B, Biointerfaces, 2002;26 (3): 213-222.
  • 8Prabha S, Zhou W Z, Panyam J and Labhasetwar V. Sizes dependency of nanoparticles mediated gene transfection: Studies with fractionated nanoparticles(J). International Journal of Phannaceutics, 2002; 244(1-2): 105-115.
  • 9Roy K, Mao H Q, Huang S K and Leong K W. Oral Gene Delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy (J). Nature Medicine, 1999, 5(4): 387-391.
  • 10ShenGX(沈关心),ZhouRL(周汝麟).Modem Experimental Techology of Immunology. 2nd. (M). Wuhan: Hubei Science and Technology Press, 2002.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部